EMEA-001172-PIP01-11
Key facts
Active substance |
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/259/2011
|
PIP number |
EMEA-001172-PIP01-11
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of glaucoma
|
Route(s) of administration |
Ocular use
|
Contact for public enquiries |
Alcon Laboratories (UK) Ltd.
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|